Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy

Jacek Capala, Kirsten Bouchelouche

92 Citationer (Scopus)

Abstract

HER2 overexpression is correlated with aggressive tumor behavior and poor clinical outcome. Therefore, HER2 has become an important prognostic and predictive factor, as well as a target for molecular therapies. The article reviews recent advances in molecular imaging of HER2 that could facilitate individual approaches to targeted therapy of HER2-positive breast cancers.
OriginalsprogEngelsk
TidsskriftCurrent Opinion in Oncology
Vol/bind22
Udgave nummer6
Sider (fra-til)559-66
Antal sider8
ISSN1040-8746
DOI
StatusUdgivet - 1 nov. 2010

Fingeraftryk

Dyk ned i forskningsemnerne om 'Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy'. Sammen danner de et unikt fingeraftryk.

Citationsformater